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Abstract
Rectal cancer has the eighth highest cancer incidence worldwide, and it is increasing in young individuals.
However, in countries with a high human development index, mortality is decreasing, which may reflect better
patient management, imaging being key. We rely on imaging to establish the great majority of clinical tumour
features for therapeutic decision-making, namely tumour location, depth of invasion, lymph node involvement,
circumferential resection margin status and extramural venous invasion. Despite major improvements in technique
resulting in better image quality, and notwithstanding the dissemination of guidelines and examples of
standardised reports, rectal cancer staging is still challenging on the day-to-day practice, and we believe there are
three reasons. First, the normal posterior pelvic compartment anatomy and variants are not common knowledge to
radiologists; second, not all rectal cancers fit in review paper models, namely the very early, the very low and the
mucinous; and third, the key clinical tumour features may be tricky to analyse. In this review, we discuss the normal
anatomy of the rectum and posterior compartment of the pelvis, systematise all rectal cancer staging key points
and elaborate on the particularities of early, low and mucinous tumours. We also include our suggested reporting
templates and a discussion of its comparison to the reporting templates provided by ESGAR and SAR.
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Key points
 Imaging is the pillar upon which therapeutic
decisions are made in rectal cancer patients.
 Knowledge of normal anatomy and variants of the
posterior pelvic compartment is mandatory for
rectal cancer staging.
 We provide a roadmap for rectal cancer staging
which includes anatomy and anatomic variants of
the posterior pelvis, all key staging features and the
particularities of early, low and mucinous tumours.
Background
Rectal cancer is one of the best examples of success of
clinical research in the past 40 years. Total mesorectal
excision (TME) alone, as opposed to blunt “pelvic rape”,
resulted in an increase in the 5-year cancer-specific sur-
vival rate from 38 to 68% [1]. The introduction of pre-
operative chemoradiation therapy in high-risk patients
reduced local recurrence rates to 6% as opposed to 13%
when given post-operatively [2]. We have slowly moved
from specialty-centred decisions to generalised multidis-
ciplinary patient management in which radiology be-
came the pillar for risk stratification. In fact, with a
differentiated multimodality treatment based on dedi-
cated preoperative MR imaging, local recurrence has lost
relevance compared to early diagnosis, treatment-related
morbidity and metastatic disease prevention and control
[3]. Despite major improvements in technique resulting
in better image quality, and notwithstanding the dissem-
ination of guidelines and examples of staging templates,
rectal cancer staging is still challenging. It requires a
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thorough convolution of radiologists with normal anat-
omy and technical pitfalls and a clear and systematised
knowledge of the key imaging features of rectal cancer
for decision-making. In this review, we have first focused
on the normal anatomy of the posterior compartment of
the pelvis, including the definitions of high/mid/low rec-
tum, compartment boundaries, rectal blood supply and
lymphatic drainage, and then systematised the staging
key points, namely T staging and sub-staging, N staging
and tumour deposits, M staging, circumferential margin
of resection and extramural venous invasion. We have
further included a discussion on the particularities of
early, low and mucinous rectal cancers and provided our
own staging templates. Even though no paper will ever
replace validated experience and advice from senior ex-
perts, we aim to contribute to an easier and smoother
training of interested radiologists.
Main Text
MR imaging of the normal rectum
From where up to where down
The rectum ends distally at the anorectal transition. The
anorectal transition may be defined by 2 anatomic land-
marks: the first is an abrupt increase in thickness of the
inner muscular layer, corresponding to the upper limit
of the internal sphincter of the anus (Fig. 1a) [4]. The
other is the superior border of the puborectalis—the
sling or U-shaped portion of the levator ani muscle com-
plex (or “pelvic diaphragm”)—which is anchored anteri-
orly to the inferior pubic ramus on each side of the
symphysis pubis and posteriorly to the anococcygeal
raphe (Fig. 1b) [5, 6].
The definition of the upper limit of the rectum is an
intraoperative definition, corresponding to the lower
limit of the large bowel that can be mobilised away from
the spinal column. On MR imaging, it may correspond
to the point of inflection between the more vertical rec-
tum and the more horizontal rectosigmoid or “sigmoid
take-off” [7–9] (Fig. 2a). The actual sigmoid starts at an-
other more horizontal inflection, away from the lesser
pelvis (Fig. 2b).
The rectum may be divided into 3 segments: upper,
mid and low. The upper rectum is located above the
lower limit of the anterior peritoneal reflection (see
below) (Fig. 2a) [8]. The low rectum is surgically defined
as the portion of the rectum that is less than 6 cm from
the anal verge, visible on sagittal T2-WI as the lower limit
of hypointense skin change (Fig. 2a) [10, 11]. The middle
rectum is in between these two segments (Fig. 2a).
Keep in mind For standardization purposes, we recom-
mend rectal cancer location measurements to be made
based on the central axis of both the anal canal and rec-
tum (Fig. 2a). Rectum definitions should be clear to the
whole multidisciplinary team given older definitions are
still frequently utilised. The latter include the distal-
most 16 cm, 15 cm or 12 cm of the large bowel and the
segment spanning from the anorectal transition to S3 or
to the promontory [12].
The rectal wall
Although peristalsis, pulsation, breathing and suscepti-
bility from bowel air may cause image artefacts, in opti-
mal conditions, the layers of the rectal wall should be
clearly defined. The mucosa is a thin, dark regular line
on T2 (Fig. 3a). It is underlined by the T2-hyperintense
fat-rich submucosa which is highly variable in thickness
from patient to patient and also according to the degree
of distension of the rectum (Fig. 3a). The muscularis
propria is dark on T2 (similarly to skeletal muscle) and
Fig. 1 The anorectal transition may be defined by the upper limit of the internal sphincter of the anus (between arrows in a), which is generally
much thicker than the inner muscular layer of the muscularis propria of the rectum, or by the plane that intersects the superior border of the
puborectalis muscle (between arrows in b), which may be asymmetric, as in the example depicted
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is composed of an inner circular layer and an outer lon-
gitudinal layer (Fig. 3a). Once again, its thickness varies
according to the degree of distension of the rectum. The
longitudinal layer of the muscularis propria is covered
by the fat-rich mesorectum, which is highly variable in
thickness according to body composition and unevenly
distributed (Fig. 3a–d). Anteriorly, it may be very thin or
even not visible, particularly in the 2 cm above the ano-
rectal transition (Fig. 3c, d) [12].
Keep in mind A small enema before MR imaging may
minimise susceptibility from bowel air [13]. Spasmolytic
agents such as butylscopolamin or glucagon significantly
reduce artefacts from peristalsis and may be adminis-
tered to improve image quality in the absence of contra-
indications (Fig. 4) [13]. Our rectal cancer staging
acquisition parameters at 1.5T are presented in Table 1.
The envelope
The rectum is out of the peritoneal cavity, and its ser-
osa—the mesorectal fascia—is displaced radially to con-
tain a large fatty cushion—the mesorectum. The
mesorectal fascia is usually described as a pencil-drawn
hypointense line on T2. However, it is a multi-layered
envelope that presents with gaps, particularly at its lower
antero-lateral aspect, which means that at some points it
may not be visible and we must extrapolate its expected
position (Fig. 5a) [14]. Also, it is juxtaposed to the par-
ietal fascias, which contain the autonomic nerves [14].
As such, multiple pencil-drawn T2-hypointense lines
may be apparent, in which case the innermost should be
considered (Fig. 5b). The virtual space between the
mesorectal fascia and the parietal fascias is the holy plane
of rectal cancer surgery—the plane through which the sur-
geon must perform sharp dissection to obtain optimal on-
cologic results with minimal bleeding and autonomic
nerve damage-related morbidity.
The parietal fascias have different names according to
location. Anteriorly, in between the anterolateral neuro-
vascular bundles and extending craniocaudally from the
pelvic floor to the peritoneal reflection is the trapezoidal-
shaped Dennonvillier fascia (Fig. 5c, d) [15]; posteriorly,
covering the sacrum, is the presacral fascia (Fig. 5d); and
extending between the mesorectal fascia and the presacral
fascia at the level of S2/S4 is the Waldeyer’s/rectosacral
fascia (Fig. 5e). It divides the retrorectal space into super-
ior and inferior compartments [14, 16–18].
Caudally, the mesorectal fascia is in continuity with
the intersphicteric plane (Fig. 5f) [18]. Cranially, it is in
continuity with the peritoneal reflection, which is lower
anteriorly, of intermediate height laterally and higher
posteriorly. The most relevant reference while staging
rectal cancer is the anterior peritoneal reflection, which
we should look for in the plane immediately below any
pelvic small bowel loops and the sigmoid take-off. Its ap-
pearance on (oblique) axial plane is that of a seagull or
V-shaped T2-hypointense line infolding (Fig. 6a). On
mid-sagittal plane, this T2-hypointense line extends
roughly horizontally from the anterior rectal wall to the
roof of the mesorectal fascia, most commonly at the
level of the torus uterinus in women or superior bladder
in men (Fig. 6b) [19, 20]. The posterior peritoneal
Fig. 2 The upper limit of the rectum corresponds on MR imaging to the point of inflexion between the more vertical rectum and the more
horizontal sigmoid “take off” (arrow in a). The sigmoid starts at another more horizontal inflection, better visualised in the (oblique) axial plane
(arrow in b). The low rectum is the segment located < 6 cm above the anal verge and above the anorectal transition (lined in yellow in a); the
mid-rectum is located between the low rectum and the plane of the lowest point of the anterior peritoneal reflection (lined in purple in a); the
high rectum is the segment above it and below the sigmoid “take-off” (lined in pink in a). The sigmoid “take-off” or rectosigmoid transition is
lined in blue in b, while the actual sigmoid is lined in green
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Fig. 3 The rectal wall. The mucosa is visible on T2-weighted imaging as a regular thin (≈ 1 mm) hypointense line delimiting the lumen (red
arrow in a). The submucosa is hyperintense and of variable thickness (double-headed blue arrow in a). It may not be visible when the rectum is
distended. The muscularis propria is composed of an inner circular layer (green arrow in a) and an outer longitudinal layer (purple arrow in a)
which may be separated by a thin layer of fat, as in the example shown. Lying externally to it is a cushion of mesorectal fat (delimited in red in
a) that tappers inferiorly (delimited in red in c) and anteriorly, where it can be thin (between arrows in c) or even invisible (between arrows in d),
in which case the mid/low rectum appears juxtaposed to the Dennonvillier fascia
Fig. 4 Sagittal T2-weighted images before (a) and 5min after (b) IV administration of a spasmolytic agent (butylscopolamine 20 mg). Notice how
the walls of the rectum and small bowel are much better defined due to limited peristalsis
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reflection is located most commonly 1 to 4 cm below
S1–S2 and corresponds to the upper limit of the rectum
[21, 22]. It is not easily identified.
Keep in mind The anterior peritoneal reflection can
easily be identified whenever there is a small amount of
free peritoneal fluid because in the supine position it will
accumulate at the deepest point of the rectovesical or
rectouterine pouch, exactly where the peritoneum “re-
flects” (Fig. 6c). The height of the anterior peritoneal
reflection is variable, and it may not be visible in > 10–
25% of cases [19, 20].
The blood supply
Arterial blood arrives at the rectum through 4 routes.
The main route is the superior rectal artery, which is the
continuation of the inferior mesenteric artery when it
crosses the left common/internal iliac artery (Fig. 7a)
[22]. The middle rectal arteries are inconsistent (present
in 36–57% of cases) and highly variable. They may be
unilateral, double or treble and may arise from the in-
ternal iliac or one of its branches [22–24]. They usually
reach the mesorectum through either its antero-lateral
or postero-lateral aspect, roughly 6 cm above the pelvic
floor (Fig. 7b) [22]. The inferior rectal arteries originate
from the internal pudendal arteries below the levator ani
muscle, cross the ischioanal fossa anteromedially and irri-
gate the distal rectum, anal canal and internal and external
anal sphincters (Fig. 7c) [24]. The middle sacral artery
courses inferiorly along the surface of the lumbo-sacral ver-
tebrae, within the presacral space and usually contributes
with small vessels to the posterior surface of the rectum
(Fig. 7d) [24]. The 4 rectal arterial routes communicate ex-
tensively through intramural anastomosis. However, in the
posterior and inferior portion of the low rectum, there is a
relatively vessel-deficient area which may explain why most
anastomotic leaks after low anterior resections (LAR) occur
in this location (Fig. 8) [22].
The venous drainage takes place through both an
outer muscularis plexus that extends longitudinally from
the anterior peritoneal reflexion down to the levatior
ani, and an inner submucosal plexus which runs through
the whole extension of the rectum and continues down
to the anus [22]. Both plexus anastomose superiorly give
rise to the superior rectal vein, draining the roughly
upper 2/3 of the rectum into the portal circulation
through the inferior mesenteric vein [22]. Inferiorly, the
inner plexus becomes the inferior rectal vein. A middle
rectal vein may be found in about 32.6%, usually unilat-
erally and rarely accompanied by a middle rectal artery.
Inferior and middle rectal veins drain roughly the distal
1/3 of the rectum into the systemic circulation through
the internal iliac vein [22, 25].
Keep in mind Surgeons may find information on the
presence of middle rectal artery(ies) and vein(s), their
route and calibre useful to prevent unexpected bleeding,
and as such, we should provide that information on staging
reports. The fact that the lower 1/3 of the rectum drains
into the systemic circulation rather than the portal circula-
tion may at least partially justify the higher rate of lung me-
tastasis in patients with low rectal cancer [26].
The lymphatic drainage
The intramural lymphatic network drains to extramural
lymphatics that in general follow the course of blood
vessels [24]. Along the course of lymphatics within the
mesorectum, we find a variable number of lymph nodes
(mean 6.8 to 73.7 in surgical TME specimens with varied
disease processes, surgical technique and pathology pro-
cessing) [27–30]. Their size ranges between 2 and 10
mm in normal subjects, and they are more numerous
Table 1 MR acquisition parameters at a 1.5 T Ingenia Philips Healthcare®, Best, The Netherlands equipment











Echo time (ms) 85 100 100 90 10
Repetition time (ms) 5692 2000 2660 4288 683
Echo train length 18 16 21 – –
Slice thickness (mm) 3 3 3 5 5
Gap (mm) 0.3 0.3 0 0 1
Matrix 416 × 465 200 × 179 252 × 223 76 × 65 292 × 300
Field-of-view (mm) 250 × 328 160 × 160 200 × 200 200 × 200 290 × 348
In-plane resolution (mm2) 0.6 × 0.7 0.8 × 0.8 0.8 × 0.9 2.6 × 3.01 1 × 1.16
Signal averages 1 2 2 7 1
*Oblique axial scans are acquired perpendicular to the long axis of the rectal wall at tumour location
+Spectral pre-saturation with inversion recovery is utilised for fat saturation. B values of 0 and 1400 s/mm2 are employed
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and larger in the upper and posterior mesorectum (Fig. 9)
[27–30]. Normal/reactive lymph nodes on T2-WI MR im-
aging appear homogeneous in 48 to 88% and with smooth,
sharply demarcated borders in 80 to 94% of cases [31, 32].
In approximately 70% of cases, they will show a smooth
and regular, uninterrupted chemical shift effect on T2-WI
in the phase encoding direction, likely the result from the
sharp interface between the water-rich subcapsular sinus
Fig. 5 The mesorectal fascia may present with gaps, particularly anterolaterally (arrows in a). It is a multilayered envelope and as such multiple
hypointense lines may be apparent (arrows in b). Anteriorly, in between the neurovascular bundles, extending from the peritoneal reflection
down to the pelvic floor, the mesorectal fascia is juxtaposed to the Dennonvillier fascia (between red arrows in c and d). Posteriorly, it is
juxtaposed to the presacral fascia (blue arrows in d). Sometimes, the presacral compartment is divided by the Waldeyers fascia (arrow in e) into
superior and inferior compartments. Inferiorly, the mesorectal fascia tappers and is “lost” within the intersphincteric plane (arrows in f)
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Fig. 6 The peritoneal reflection, when visible, may present with a seagull or V-shaped appearance on the (oblique) axial plane (arrow in a). The
sagittal plane is depicted as a hypointense line extending from the rectal wall to the roof of the mesorectal fascia (arrow in b). It is more easily
identified whenever there is a small amount of peritoneal effusion, which will accumulate immediately above it (arrow in c)
Fig. 7 The rectum’s arterial supply has 3 to 4 routes. The main route is the superior rectal artery (arrow in a). The middle rectal arteries are
inconsistent but may be present in up to 57% of cases. In b, a large calibre right middle rectal artery (arrow) arising from the internal iliac artery
pierces the mesorectal fascia at its anterolateral aspect. The inferior rectal arteries originate from the internal pudendal arteries, are usually small in
caliber and cross the ischioanal fossae towards the anal canal (arrows in c). The middle sacral artery courses down along the lumbosacral
vertebrae, within the presacral space (arrow in d)
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and the mesorectal fat (Fig. 10) [32]. Lymph nodes located
within the mesorectum, along the inferior and superior
rectal vessels, along the inferior mesenteric vessels and
along the internal iliac vessels and their branches are con-
sidered regional.
Keep in mind Although considered regional by the
AJCC, internal iliac lymph nodes, commonly referred to
as “lateral pelvic lymph nodes”, are outside of the “cir-
cumferential margin of resection” in rectal cancer sur-




We find reading the endoscopy report carefully to aid in
the interpretation of the images—we should check
whether the gastroenterologist found a suspicious focus
in a benign polyp or a clearly malignant infiltration of
the rectal wall and pay special attention to the lesions’
shape description, estimated location, size and circum-
ference of involvement. Also, we believe DWI may help
locate small primary tumours, given on high b value im-
ages they will present most commonly with high signal
intensity, but high-resolution T2-weighted imaging (T2-
WI) perpendicular to the long axis of the tumour is the
pillar of T staging given it provides the highest rectal
wall layer detail. The maximum depth of tumour inva-
sion will determine the MR imaging T stage (mrT) (Figs.
11 and 12).
Although NCCN guidelines consider any tumour ≥
mrT3 eligible for neoadjuvant therapy, in many European
countries, mrT3 sub-classification according to the depth
of invasion beyond muscularis propria is incorporated in
the decision-making framework (Fig. 11) [33, 34]. Neoad-
juvant therapy is, according to European (ESMO) guide-
lines, reserved for tumours > mrT3b which pose a higher
risk of local recurrence (23.6% vs 10.4%) [34]. Reported
MR imaging accuracy for the assessment of T stage is vari-
able, ranging from 66 to 94% using pathology as a refer-
ence standard [35, 36]. The main difficulty is the
differentiation between T2 and T3, and discriminating be-
tween the two is particularly relevant on low tumours
given the much thinner cushion of mesorectal fat and
consequent proximity to sphincter complex and middle
pelvic compartment structures [35, 36]. T2 tumours may
present with desmoplastic reaction leading to overstaging
as T3. Desmoplasia tends to present as thin spiculae of
T2-hypointensity surrounding invaded muscularis propria,
Fig. 8 Patient who underwent low anterior resection for rectal cancer presented with a posterior colorectal anastomotic leak which became a
chronic fluid collection (between arrows in a and b)
Fig. 9 Normal distribution of lymph nodes in the mesorectum
(sagital minimum intensity projection). Lymph nodes are more
numerous and larger in the high posterior mesorectum (arrow
points to the largest lymph node but a few more are
visible upstream)
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whereas T3 tumours usually present with a broad-based
or nodular T2-intermediate-signal front at mesorectal fat
[37].
Keep in mind The maximum depth of invasion tends to
occur at the tumour’s centre, and in large tumours,
orientation of the slices perperdicular to it may be the
most useful. On the other hand, it is common for the tu-
mour’s periphery to overhang the rectal wall into the
lumen (Fig. 12c, d, f).
The circumferential margin of resection
The circumferential margin of resection (CRM) is the
plane where surgeons must dissect in order to perform a
standardised total mesorectal excision (TME). It corre-
sponds to the full circumference of the mesorectal fascia
and, in tumours extending down into the anal canal, to
the intersphincteric plane, with which the mesorectal
fascia is in continuity inferiorly. The minimum distance
between the tumour and the circumferential margin of re-
section on high-resolution T2-WI acquired perpendicular
to its long axis should be recorded, as well as its location
and extent. CRM is considered involved if the tumour lies
< 1mm from it (Fig. 13a) [38]. Although MR imaging was
considered very accurate and reliable at predicting a clear
margin in 2 seminal studies by Brown et al. and Beets-Tan
et al., in a large meta-analysis, the sensitivity and specifi-
city for margin involvement using a 1-mm cutoff were of
only 76% and 88% respectively [39–41]. Margin involve-
ment at MR imaging is associated with higher local recur-
rence rates (20% vs 7.1%), worse overall survival (42.2% vs
62.2%) and disease-free survival (47.3% vs 67.2%) [39, 42].
It is considered an indication for neoadjuvant therapy by
both NCCN and ESMO guidelines [33, 34].
The extramural venous invasion
Extramural venous invasion (EMVI) on the histopath-
ology of rectal cancer surgery specimens is an independ-
ent predictor of local recurrence, distant recurrence and
worse overall survival [43]. MR imaging may detect
EMVI with low sensitivity (62%) but high specificity
(88%), using pathology as the gold standard [43]. It is
depicted as intermediate signal intensity within vessels,
with or without associated expansion and contour ir-
regularity. It is generally in continuity with the primary
tumour, but discontinuous mrEMVI may also be ob-
served. The likelihood of mrEMVI may be graded based
on an ordinal scale by Smith et al., grades 3 and 4,
Fig. 10 Patient staged as mrT3a/b mrN2b due to multiple bulky lymph nodes in the mesorectum of which one is depicted, measuring 13 mm in
the long axis and 10 mm in the short axis. The patient underwent surgery and was a pT3N0. While carefully reviewing the lymph node
appearance on T2-WI, we notice they all presented with well-defined borders, homogeneous signal intensity and a preserved chemical
shift effect
Fig. 11 T stages and substages. T1is: tumour in situ; T1sm1/2:
tumour invades the submucosa, but not its full thickness; T1sm3:
tumour invades the full thickness of the submucosa; T2 early:
tumour focally invades the muscularis propria; T2 advanced: tumour
invades the full thickness of the muscularis propria; T3a: tumour
extends < 1mm into the mesorectal fat; T3b: tumour extends
between 1 and 5mm into the mesorectal fat; T3c: tumour extends
between 5 and 15 mm into the mesorectal fat; T3d: tumour extends
> 15mm into the mesorectal fat; T4a: tumour invades the
peritoneum; T4b: tumour invades adjacent organs
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Fig. 12 Examples of differently T-staged tumours. a, b Arrows point to an early polypoid tumour occupying the full depth of the submucosa
centrally and therefore staged clinically as mrT1sm3/early T2. Total mesorectal excision was performed, and at pathology, it corresponded to a
T1sm3. c, d This ulcerated tumour extends in depth through the full thickness of the muscularis propria and was therefore staged as an MR
advanced T2 (red arrows), which was confirmed at pathology. Notice how the periphery of the tumour overhangs the rectal wall both in the axial
and coronal planes (blue arrows). e, f This mid-high, sub-circumferential rectal cancer extends 4 mm into the mesorectal fat at its most central
area (red arrows) and was therefore staged as T3b. Notice the overhanging edges on the sagittal plane (blue arrows in f). g, h An anterior mid-
high rectal cancer crosses the Denonvillier fascia and the peritoneal reflection to invade the seminal vesicles in this male patient, corresponding
to an mrT4b. The patient underwent chemoradiation and is currently under palliative treatment due to distant metastatic disease
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characterised by the presence of intermediate signal in-
tensity within vessels (Fig. 14), being associated with a
lower relapse-free survival (35% vs 74%) [43, 44] and a
higher risk of synchronous (OR 5.68; 95 CI 3.75–8.61)
and metachronous (OR 3.91; 95 CI 2.61–5.86) metastasis
[45]. Its presence is considered an indication for
neoadjuvant therapy according to ESMO guidelines [34].
It is not part of the NCCN guidelines [33].
Lymph node involvement and tumour deposits
In rectal cancer patients, nearly 48% of positive lymph
nodes are ≤ 5 mm. As such, size criteria to identify nodal
Fig. 13 Circumferential margin of resection involvement. a A T3d tumour invades the mesorectal fascia on the left side (arrow). b A 1–2 mm fat
plane between this mrT3b low rectal cancer and the sphincter complex (arrow) is observed and as such the circumferential margin of resection
may be considered free
Fig. 14 MR extramural venous invasion (mrEMVI) is characterised by the presence of intermediate signal intensity tumour signal within vessels,
which may be expanded (arrows in a to d) with (arrow in a) or without contour irregularity
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involvement are not reliable [27–30, 46]. Although
normal lymph nodes are more numerous and larger
in the upper and posterior mesorectum (Fig. 9), the
incidence of nodal metastases is the same in anterior,
lateral and posterior locations [27–30]. Regional posi-
tive lymph nodes in a more cranial location are asso-
ciated with a higher risk of distant metastases [46].
Advanced T stage is associated with a higher number
of positive lymph nodes, particularly small in size
[46]. Most involved lymph nodes occur within the 1
cm proximal and the 1 cm distal to the tumour [47],
and further spread occurs cranially in more than 90%
of cases [48–50]. In the case of rectal cancers at the
level of or below the peritoneal reflection, particularly
≥ T3, further spread may also occur to the lateral
pelvic compartments [30, 51]. In fact, the lower the
tumour, the more likely lateral spread is, going from
11.4% between 4 and 6 cm from the anal verge to
33.3% below 4 cm (Fig. 15) [51].
For nodes in the lateral pelvis, mostly size criteria have
been tested, with variable cutoffs and variable outcomes
[52–56]. According to research by the Lateral Node
Study Consortium, in the particular case of cT3/4 low
tumours, lateral lymph nodes with a short axis of at least
7 mm on staging MR have a significantly higher risk of
lateral recurrence and lateral lymph node dissection in
such cases may reduce lateral recurrences significantly
[57]. For nodes > 3 mm in the mesorectum, contour ir-
regularity, signal heterogeneity and interruption or ab-
sence of chemical shift artefact on T2-WI are the most
Fig. 15 a This patient presents with a polypoid tumour (blue arrow in a) located 7 cm above the anal verge. Tumour is underlined by a clear,
uninterrupted, hyperintense submucosal fat plane and may as such be staged as mrT1 sm1/2. The patient also presented with a hypointense
round lymph node in the mesorectum (red arrow), at tumour plane, 10 o’clock, with a slightly irregular contour anterolaterally. A very bulky,
irregularly contoured, heterogeneous lymphadenopathy was found in the obturator space of the right lateral pelvic sidewall. The patient was
selected for chemoradiation therapy
Fig. 16 This patient with a large T3 MRF+ rectal cancer (yellow arrow in a) presents with a hypointense, highly irregular, intermediate-to-low
signal intensity nodule in the mesorectum (red arrows in a and b) that does not interrupt the course of a vein but is irregular enough for us to
admit the possibility of an extranodal deposit (mrENTD). The patient also presented with a round, hypointense slightly heterogeneous and
slightly irregularly contoured lesion which we believe to be a lymphadenopathy (blue arrow in b)
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reliable criteria for tumour infiltration [31, 32, 39]. No
reliable criteria exist for nodes smaller than that [31, 39].
N staging based on MR imaging may be reported sym-
metrically to the TNM staging system.
Tumour deposits are defined according to AJCC 2018
as discrete tumour nodules in the rectal cancer path-
ology specimen within the lymphatic drainage area of
the primary tumour without identifiable lymphatic, vas-
cular or neural tissue, irrespective of their morphology
[58]. If a vessel wall/remnant is identified, the lesion
should be classified as lymphovascular invasion, further
subclassified as either lymphatic or venous. If neural
structures are identified, the lesion should be classified
as perineural invasion. Tumour deposits are found in
3.3% of rectal cancer specimens without lymph node
involvement, in which case N1c should be recorded
(TNM classification), but when lymph nodes are posi-
tive, tumour deposits are not to be added to the total
positive lymph node count. Lord et al. are currently
studying the differentiation of extranodal tumour de-
posits (mrENTDs) from involved lymph nodes on MR
imaging—the subject of an ongoing clinical trial
named COMET [59]. Their imaging definition is quite
different from the pathologic definition described
above [59]. mr-ENTDs are described as comet-shaped
nodules of tumour which appear to directly interrupt
the course of a vein (Fig. 16) [59].
Although T stage now prevails, lymph node positivity
on MR imaging is still considered an indication for
neoadjuvant therapy according to NCCN guidelines,
whereas ESMO guidelines admit surgery upfront for
N positive patients without involvement of the cir-
cumferential margin of resection or mrEMVI, prefera-
bly ≤ T3a-b [33, 34].
Keep in mind In the authors’ perspective, the differenti-
ation between positive lymph nodes with extracapsular
extension, ENTDs and discontinuous EMVI on MR im-
aging may be difficult. Evidence suggests all of these en-
tities entail a worse outcome compared to confined
lymph node involvement. As such, pointing extranodal
Fig. 17 A patient with an mrT3d MRF+ high rectal cancer also presents with a very irregular hypointense lesion in the high mesorectum (red
arrow in a) that appears to both interrupt the course of a vein suggesting mrENTD (blue arrow in a) and to grow within it suggesting
discontinuous mrEMVI (blue arrow in b). It is also in continuity with a round, irregular and heterogeneous structure appearing to be a positive
lymph node with extracapsular extension (yellow arrows in b and c). The patient presented with synchronous metastatic liver disease, visible on
b900 DWI (green arrows in d)
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tumour on staging reports may be more important than
matching its exact pathologic diagnosis (Fig. 17) [60].
The specific scenarios
The very early rectal cancers
Very early rectal cancers, defined as low grade (G1/G2)
cT1 cN0 cEMVI- tumours [33], can be subclassified based
on the depth of invasion of the submucosa, tumours with
< 1mm of submucosal invasion having a practically null
risk of lymph node metastasis [61]. This means transanal
endoscopic microsurgery (TEM) can provide similar out-
comes to TME in these patients, with much reduced mor-
bidity and mortality [34]. The risk of lymph node
metastases in cT1 tumours extending beyond 1mm is
relatively low (≅ 10%), particularly if G1/G2, V0, L0 [34,
62] and TEM may still be a reasonable upfront approach.
MR imaging may have a role in the selection of these pa-
tients: Balyasnikova et al. could differentiate patients with
either no evidence of submucosal invasion or a visibly
spared ≥ 1mm submucosa (mrT1 sm1/2)—considered eli-
gible for TEM, from patients with no visibly spared sub-
mucosa or partially preserved muscularis (mrT1 sm3/
earlyT2), with an accuracy of 89% and a good interob-
server agreement (k = 0.74) [62]. Results of a larger UK
multi-institutional trial (SPECC) are now awaited. MR im-
aging may also help assess lymph node involvement up-
front and monitor recurrence after TEM. Fig. 18 depicts
examples of both mrT1sm1/2 and mrT1sm3/earlyT2.
The low rectal cancers
A tumour with its lower edge less than 6 cm above the
anal verge is considered a low rectal cancer [63](Fig. 19).
Its prognosis is worse, with higher rates of local recur-
rence and poorer survival [63]. These figures may result
from the inferior mesorectal tapering and closer proximity
of tumours to the pelvic floor and middle pelvic compart-
ment structures, requiring more mutilating surgical proce-
dures and being associated with higher rates of margin
positivity [64]. A specific MR imaging staging system was
developed by Shihab et al. to address the particularities of
low rectal cancer and aid in surgery planning [63, 65, 66].
According to it, tumours confined to the bowel wall not
extending through its full thickness are considered mrLR1,
tumours replacing the muscle coat but not reaching the
intersphinteric plane are considered mrLR2, tumours in-
vading the intersphincteric plane or lying within 1mm to
the levator muscle are considered mrLR3 and tumours in-
vading the external anal sphincter and being within 1mm
Fig. 18 Two different patients with two different early rectal cancers are depicted in a and b. In a, a thin submucosal fat plane is observed
between the intermediate signal intensity tumour and the tented muscularis propria. Tumour may therefore be staged as mrT1sm1/2. Pathology
of the total mesorectal excision specimen revealed a pT1sm1; in b, the tumour abuts the inner circular layer of the muscularis propria and may
therefore be staged as mrT1sm3/earlyT2. Pathology of the total mesorectal excision specimen revealed a pT1sm3
Fig. 19 A low rectal cancer is depicted with its lower edge 48 mm
above the anal verge. Measurement is made from the central axis of
the anus to the central axis of the rectum at the plane of the lower
edge of the tumour
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and beyond the levator muscle, with or without invading
adjacent structures, are considered mrLR4 (Fig. 20) [66].
mrLR1 tumours confined to the low rectum may be
approached by LAR, in which the mesorectum is removed
en bloc down to the pelvic floor. mrLR1 tumours
extending into the anal canal may be approached with a
LAR + intersphincteric dissection [4]. Low colorectal
anastomosis or coloanal anastomosis may be performed
upon favourable sphincter competence in these proce-
dures, to avoid a permanent stoma, but the rate of
Fig. 20 Four low rectal cancers from 4 different patients are depicted. In a and b, a posterior mrT1sm3/early T2 tumour is depicted. It is classified
as LR1 according to the low rectal cancer classification given it does not extend through the full thickness of the rectal wall. In c and d, a right
anterior quadrant mrT2 tumour extending inferiorly into the anal canal is depicted, which invades the full thickness of the internal anal sphincter
without extending into the intersphincteric plane—mrLR2. In e and f, a T3 tumour extending into the low mesorectum to within 1 mm of the
left levator muscle is classified as mrLR3; in g and h, a low tumour extends through the mesorectal fat reaching the left levator muscle, therefore
classified as mrLR4
Santiago et al. Insights into Imaging          (2020) 11:100 Page 15 of 21
anastomotic leak and pelvic sepsis is increased and may
significantly reduce patient quality of life. mrLR2 may be
approached with standard abdominoperineal excision
(SAPE), also known as an intersphincteric APE, in which
the distal colon, rectum and anal sphincter are removed
en bloc [4, 67]. When surgical treatment is considered for
mrLR3-4, an extralevator abdominoperineal excision
(ELAPE) is oncologically safer (less chance of R1 resec-
tion), in which dissection along the mesorectal fascia ends
caudally at the levator origin and is met by a perineal dis-
section along the outer surface of the levators [4, 68].
ELAPE is associated with lower perforation and margin
involvement rates, and consequent lower local recurrence
rates than SAPE, albeit at the cost of higher perineal
Fig. 21 In a to c, we observe a low/mid rectal cancer with a predominance of high signal intensity in accordance with a mucinous histologic
subtype. It presents with bilateral (arrows in a) and anterior (arrow in b) transgression of the mesorectal fascia, extending into the pelvic sidewall
and middle pelvic compartment, respectively. It may not be easy to define its exact boundaries due to the approximation of signal intensity to
that of fat (arrow in c). b0 DWI images are fat-suppressed T2-WI and may aid in the distinction (arrow in d). T1WI may work even better, namely
to define or exclude a fat plane between tumour and circumferential margin of resection. In e, a low mucinous rectal cancer appears to invade
the levator muscle on T2-WI but in the corresponding T1WI (f), we see a thin fat plane between the two.
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morbidity [68]. For tumours located both above and
below the puborectalis sling or located anteriorly, at
the level of the prostate, pelvic exenteration may be
more appropriate [69]. In the particular case of very
low rectal tumours (< 4 cm from the anal verge), mrT
> 2 may by itself be an indication for neoadjuvant
therapy according to European guidelines, whereas for
higher locations, it may be reserved for mr > T3b if
good quality TME can be assured [33]. Examples of
mrLR1 - 4 are given in Fig. 20.
Keep in mind In low rectal tumours, additional oblique
axial and coronal T2-WI planes perpendicular and paral-
lel to the long axis of the anal canal, respectively, should
be acquired when needed. The anal verge may be identi-
fied on sagittal T2-WI as the lower limit of the perianal
hypointense skin change (Fig. 19).
The mucinous rectal cancers
Mucinous adenocarcinomas comprise 10–20% of all rec-
tal cancers, tend to affect younger patients and are
Fig. 22 A standardised report proforma for mid/high rectal cancer staging is depicted. In blue, a single option should be chosen per field
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defined histologically by the presence of extracellular
mucin in more than 50% of the tumour stroma [69].
There is an association with a history of inflammatory
bowel disease and pelvic radiotherapy [69]. This histo-
logic subtype may be associated with a higher T stage
upon diagnosis, a greater risk of metachronous metasta-
ses and a worse response to chemoradiation, but results
regarding the impact on overall survival are conflicting
[70, 71]. Although the definition is histologic, it may be
that mucinous tumours are more efficiently detected on
T2-WI MR imaging than on endoscopic biopsy, imaging
definition being more than 50% high signal intensity
areas within the tumour—areas with a signal intensity
similar to or brighter than that of the mesorectal fat [69,
71]. MR imaging-detected mucinous tumours carry a
similarly worse prognosis relative to histology, with
Fig. 23 A standardised report proforma for low rectal cancer staging is depicted. In blue, a single option should be chosen per field
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poorer responses to chemoradiation and worse disease-
free survival [69] (Fig. 21).
Keep in mind Whenever in doubt, DWI b0 may be use-
ful for the distinction between fat signal, which will be
suppressed, and mucin, which will remain bright. Also,
we find high-resolution T1-WI may help define the
boundary between mucin and fat (Fig. 21).
Rectal cancer staging templates
Figures 22 and 23 depict our suggested templates for the
staging of mid/high and low rectal cancers respectively.
In this section, we discuss the small deviations from
SAR and ESGAR consensus guidelines and their
reasoning.
Our patients routinely perform a small enema shortly
before MR imaging to empty the rectum, which signifi-
cantly reduces susceptibility artefacts due to air content,
improvement being particularly relevant for DWI [72].
Intravenous butilscopolamine is also administered rou-
tinely at our centre in the absence of contraindications,
between scout and (oblique axial) T2-WI acquisitions, to
minimise artefacts due to peristalsis. Neither the use of
small enema nor the use of spasmolytic agents has
reached consensus by SAR or ESGAR expert panels and
is therefore considered optional according to their re-
spective guidelines [13, 73].
Our acquisition protocol is exhibited in Table 1. We
routinely perform DWI in staging examinations to help
locate small lesions and to serve as a baseline for re-
sponse assessment. Although DWI is a recommended
sequence according to SAR consensus guidelines, it is
considered optional upon staging according to ESGAR
consensus guidelines [73, 74]. We do not administer
intravenous contrast for rectal cancer staging, which is
optional according to both guidelines. The exception is a
suspicion of pelvic sepsis or fistulization, in which case
we find contrast very helpful to delineate abscesses and
fistulous tracts respectively. We include an unenhanced
T1 sequence, as recommended by SAR [13, 73], which
provides an overview of the whole pelvis and may help
characterize incidental bone ou genito-urinary lesions. It
may also help delimit mucinous tumours, as discussed
in the “The mucinous rectal cancers” section.
With respect to staging key points, all of our patients
are staged with MR imaging unless an absolute contra-
indication is known, even early tumours, and as such, we
have decided to include early tumour sub-staging in our
templates as by Balyasnikova et al. [62], which is not part
of either SAR or ESGAR consensus guidelines [13, 73].
Also, we have kept the mrLR classification for low rectal
tumours [66] given it is well known by our multidiscip-
linary team. Even though the specific mrLR term is not
utilised in the templates by SAR or ESGAR, the depth of
invasion subclass options for low tumours is presented
similarly in both [13, 73]. We have used the 5-point
scale by Smith et al. [43] for mrEMVI assessment since
the very beginning of our practice, and we find it helpful
for less experienced radiologists. As such, we kept it,
whereas SAR and ESGAR have adopted a simpler 3-
point and 2-point scale for that purpose, respectively
[13, 73]. Finally, our templates leave node involvement
interpretation open, whereas both SAR and ESGAR
reporting templates adopt strict mixed size-morphology
criteria [13, 73]. The reason for this deviation is our own
node-by-node analysis experience based on such criteria,
which we found suboptimal [74]. We rely on morpho-
logic criteria irrespective of size, namely shape, contour,
heterogeneity and chemical shift effect, as explained in
the “Lymph node involvement and tumour deposits”
section.
Conclusions
Pelvic MR imaging is the pillar of clinical rectal cancer
staging and the basis for optimal multidisciplinary
patient management decision-making. A thorough and
systematic knowledge of the relevant normal anatomy
and variants, of the key staging imaging features and
of the particularities of early, low and mucinous tu-
mours is mandatory for rectal cancer staging MR
image interpretation.
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